Silverback Therapeutics

Silverback Therapeutics to merge with San Diego biotech company developing EpiPen alternative
Geekwire
Fri, 07/22/22 - 10:07 am
Silverback Therapeutics
M&A
ARS Pharmaceuticals
Solid tumor biotech Silverback Therapeutics ups proposed deal size by 56% ahead of $195 million IPO
NASDAQ
Thu, 12/3/20 - 11:00 am
IPOs
Silverback Therapeutics
solid tumors
Seattle biotech firm Silverback Therapeutics aims for $100M IPO
Seattle Times, WA
Wed, 11/11/20 - 11:13 am
Silverback Therapeutics
IPOs
solid tumors
Silverback Therapeutics raises $78.5m in oversubscribed Series B financing
Pharmaceutical Business Review
Thu, 03/12/20 - 10:43 am
Silverback Therapeutics
breast cancer